Redeye updates on EG7 ahead of Q1-results (due 7 May) where we expect a stable Q1 following the typi...
Redeye updates its estimates and valuation following Momentum Group’s Q1 2026 report.
Redeye comments briefly on Hacksaw’s decision to remove Christoffer Källberg as CEO and appoint boar...
Absolent’s Q1 report showed continued organic growth of 7%, some margin improvements and a strong ca...
Reported revenue growth could remain modest or even negative in Q1 but move into positive territory ...
We expected positive organic revenue growth for Q1, but organic growth was flat.
Redeye reinforces its positive view of CombinedX, following a solid Q1 report.
* Strong growth and continued margin improvement * We raise '26e EBITA by 9%, '27e-'28e by 6% each *...
* Risk of temporary GM pressure from rising oil prices * EBITA lowered by 4% for '26e, 3% for '27e-'...
Aktia reported a soft Q1 result with PBT 25% below Infront consensus.
Redeye has a positive view on Waystream Group’s acquisition of Tellus Fiber for an upfront considera...
The main highlight in the Q1 report was the surprisingly strong order intake.
123f started FY26 on a resilient note, delivering Q1 sales of € 6.
Profitability (adj. EBITA margin) was weaker than we expected in Q1.
Gapwaves reported Q1 net sales of SEK18.8m, down 17% y/y and ~25% below Redeye's estimate of SEK25.
Oriola started of the year with a lower-than-expected improvement in adj.
Suominen reports Q1 results on May 7. There’s a lot of room to improve from the low comparison figur...
Following the license agreement with Moderna in Q4’25, Nanexa continues to advance along three paral...
* '26e-'28e adj. EBITA down 24-13% * Webstep issues weigh significantly on revenue * Trading at NTM ...
Yesterday, Bittium published its Q1'26 business review.
